| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FLJ31951 |
| Uniprot No | Q96MT1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-663aa |
| 氨基酸序列 | MAAKEKLEAVLNVALRVPSIMLLDVLYRWDVSSFFQQIQRSSLSNNPLFQYKYLALNMHYVGYILSVVLLTLPRQHLVQLYLYFLTALLLYAGHQISRDYVRSELEFAYEGPMYLEPLSMNRFTTALIGQLVVCTLCSCVMKTKQIWLFSAHMLPLLARLCLVPLETIVIINKFAMIFTGLEVLYFLGSNLLVPYNLAKSAYRELVQVVEVYGLLALGMSLWNQLVVPVLFMVFWLVLFALQIYSYFSTRDQPASRERLLFLFLTSIAECCSTPYSLLGLVFTVSFVALGVLTLCKFYLQGYRAFMNDPAMNRGMTEGVTLLILAVQTGLIELQVVHRAFLLSIILFIVVASILQSMLEIADPIVLALGASRDKSLWKHFRAVSLCLFLLVFPAYMAYMICQFFHMDFWLLIIISSSILTSLQVLGTLFIYVLFMVEEFRKEPVENMDDVIYYVNGTYRLLEFLVALCVVAYGVSETIFGEWTVMGSMIIFIHSYYNVWLRAQLGWKSFLLRRDAVNKIKSLPIATKEQLEKHNDICAICYQDMKSAVITPCSHFFHAGCLKKWLYVQETCPLCHCHLKNSSQLPGLGTEPVLQPHAGAEQNVMFQEGTEPPGQEHTPGTRIQEGSRDNNEYIARRPDNQEGAFDPKEYPHSAKDEAHPVESA |
| 分子量 | 75.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人FLJ31951蛋白的假设性参考文献示例(请注意，实际文献可能需要通过学术数据库检索验证)：
---
1. **文献名称**：*Cloning and Functional Analysis of Recombinant Human FLJ31951 Protein*
**作者**：Lee et al.
**摘要**：报道了FLJ31951基因的克隆策略及重组蛋白在大肠杆菌中的表达，验证其具有ATP结合活性，并提示其可能在细胞代谢中发挥作用。
2. **文献名称**：*FLJ31951 Regulates MAPK Signaling Pathway via Protein-Protein Interaction*
**作者**：Chen et al.
**摘要**：通过体外实验发现重组FLJ31951蛋白与MAPK通路成分相互作用，可能参与炎症反应的调控，为相关疾病治疗提供新靶点。
3. **文献名称**：*Structural Characterization of FLJ31951 Reveals a Novel Kinase-like Fold*
**作者**：Tanaka et al.
**摘要**：利用X射线晶体学解析重组FLJ31951蛋白的三维结构，发现其具有非典型激酶结构域，提示潜在催化功能或信号转导作用。
4. **文献名称**：*FLJ31951 Overexpression Promotes Tumor Angiogenesis in Breast Cancer Models*
**作者**：Gupta et al.
**摘要**：在小鼠模型中证明重组FLJ31951蛋白通过上调VEGF表达促进血管生成，可能成为乳腺癌治疗的潜在生物标志物。
---
**注意**：以上文献为模拟示例，实际研究中FLJ31951可能存在不同命名(如已归类为特定基因家族)。建议通过PubMed或UniProt(查询号如Q8NXX5)获取最新信息。若需具体文献，可进一步限定研究领域或时间范围检索。
**Background of Recombinant Human FLJ31951 Protein**
The recombinant human FLJ31951 protein, encoded by the *FLJ31951* gene (alternative symbol *C1orf131*), is a less-characterized protein implicated in diverse cellular processes. Though its precise biological function remains under investigation, bioinformatic analyses suggest potential roles in cell signaling, transcriptional regulation, or metabolic pathways. The gene maps to chromosome 1 (1q24.2) and is ubiquitously expressed in human tissues, with higher levels observed in the brain, kidneys, and testes, hinting at tissue-specific functions.
Structurally, FLJ31951 is predicted to contain conserved domains associated with protein-protein interactions, such as coiled-coil motifs, which may facilitate its involvement in multiprotein complexes. Its recombinant form is typically produced using bacterial or mammalian expression systems, enabling functional studies. Researchers utilize purified recombinant FLJ31951 to explore its interactions, enzymatic activities (if any), and potential links to diseases.
Emerging studies suggest its possible involvement in cancer progression and neurological disorders, though mechanistic insights are limited. Challenges include elucidating its molecular partners, signaling pathways, and post-translational modifications. Continued research on recombinant FLJ31951 could clarify its physiological significance and therapeutic potential, offering a foundation for biomarker discovery or targeted therapies.
×
